Hospitals haven’t gotten paid much for uninsured COVID-19 patients, study finds

Morgan Haefner –
Monday, October 12th, 2020
Print|Email.

More articles on healthcare financing: M Health Fairview to lay off 900, close medical facility ED7 hospitals with strong financesHCA to return $6B in federal COVID-19 aid.

One reason compensation under the HHS program might be restricted is an assistance that connects compensation to a primary medical diagnosis of COVID-19. Coding procedures require service providers to code a client with sepsis caused by COVID-19 with a main diagnosis of sepsis, not COVID-19. Service providers also arent needed to get involved in the reimbursement program for uninsured COVID-19 patients.

© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this material? View our policies by click on this link.

Its “uncertain how many uninsured COVID-19 patients are being billed for their care due to the fact that their companies are uninformed of this program or have actually chosen to not take part. While large medical facilities are most likely taking part in the program, smaller companies might not understand this source of funding or they might deal with administrative barriers to sending claims and getting reimbursed,” the report stated.

In April, the Trump administration said it would take cash from the Coronavirus Aid, Relief, and Economic Security Act to repay suppliers who treat uninsured COVID-19 clients. To date, HHS has paid about $881 million to about 8,000 providers under the program..

Previous estimates from the structure suggest payments to hospitals for dealing with uninsured COVID-19 clients could range from $13.9 billion to $41.8 billion.

HHS has not said how much of those funds will be used to cover treatment for uninsured COVID-19 clients.

One factor repayment under the HHS program may be limited is an assistance that ties compensation to a main medical diagnosis of COVID-19. Coding protocols need service providers to code a client with sepsis caused by COVID-19 with a primary medical diagnosis of sepsis, not COVID-19. Suppliers likewise arent required to take part in the repayment program for uninsured COVID-19 clients.

Compensation from the program is also subject to available funds. About $31.1 billion in federal financing is still available for providers, according to the research study. HHS has actually not said how much of those funds will be utilized to cover treatment for uninsured COVID-19 clients.

Learn more here.

Providers and medical facilities treating uninsured patients for COVID-19 have received little reimbursement from the federal government despite a program that aims to ensure uninsured Americans dont deal with large COVID-19-related costs, according to the Kaiser Family Foundation.